120 related articles for article (PubMed ID: 18343218)
1. Induction of expression and co-localization of heat shock polypeptides with the polyalanine expansion mutant of poly(A)-binding protein N1 after chemical stress.
Wang Q; Bag J
Biochem Biophys Res Commun; 2008 May; 370(1):11-5. PubMed ID: 18343218
[TBL] [Abstract][Full Text] [Related]
2. Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells.
Wang Q; Mosser DD; Bag J
Hum Mol Genet; 2005 Dec; 14(23):3673-84. PubMed ID: 16239242
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic targeting of mutant poly(A)-binding protein nuclear 1 suppresses protein aggregation and toxicity in oculopharyngeal muscular dystrophy.
Abu-Baker A; Laganiere S; Fan X; Laganiere J; Brais B; Rouleau GA
Traffic; 2005 Sep; 6(9):766-79. PubMed ID: 16101680
[TBL] [Abstract][Full Text] [Related]
4. In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1.
Tavanez JP; Calado P; Braga J; Lafarga M; Carmo-Fonseca M
RNA; 2005 May; 11(5):752-62. PubMed ID: 15811916
[TBL] [Abstract][Full Text] [Related]
5. Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy.
Messaed C; Dion PA; Abu-Baker A; Rochefort D; Laganiere J; Brais B; Rouleau GA
Neurobiol Dis; 2007 Jun; 26(3):546-57. PubMed ID: 17418585
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy.
Abu-Baker A; Messaed C; Laganiere J; Gaspar C; Brais B; Rouleau GA
Hum Mol Genet; 2003 Oct; 12(20):2609-23. PubMed ID: 12944420
[TBL] [Abstract][Full Text] [Related]
7. Expression of the polyalanine expansion mutant of nuclear poly(A)-binding protein induces apoptosis via the p53 pathway.
Bhattacharjee RB; Zannat T; Bag J
Cell Biol Int; 2012 Aug; 36(8):697-704. PubMed ID: 22519734
[TBL] [Abstract][Full Text] [Related]
8. A molecular pathogenesis for transcription factor associated poly-alanine tract expansions.
Albrecht AN; Kornak U; Böddrich A; Süring K; Robinson PN; Stiege AC; Lurz R; Stricker S; Wanker EE; Mundlos S
Hum Mol Genet; 2004 Oct; 13(20):2351-9. PubMed ID: 15333588
[TBL] [Abstract][Full Text] [Related]
9. Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy.
Davies JE; Sarkar S; Rubinsztein DC
Hum Mol Genet; 2006 Jan; 15(1):23-31. PubMed ID: 16311254
[TBL] [Abstract][Full Text] [Related]
10. Oculopharyngeal muscular dystrophy: potential therapies for an aggregate-associated disorder.
Davies JE; Berger Z; Rubinsztein DC
Int J Biochem Cell Biol; 2006; 38(9):1457-62. PubMed ID: 16530457
[TBL] [Abstract][Full Text] [Related]
11. Hsp105 reduces the protein aggregation and cytotoxicity by expanded-polyglutamine proteins through the induction of Hsp70.
Yamagishi N; Goto K; Nakagawa S; Saito Y; Hatayama T
Exp Cell Res; 2010 Sep; 316(15):2424-33. PubMed ID: 20542028
[TBL] [Abstract][Full Text] [Related]
12. PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression.
Klein AF; Ebihara M; Alexander C; Dicaire MJ; Sasseville AM; Langelier Y; Rouleau GA; Brais B
Exp Cell Res; 2008 May; 314(8):1652-66. PubMed ID: 18367172
[TBL] [Abstract][Full Text] [Related]
13. Study of a Taiwanese family with oculopharyngeal muscular dystrophy.
Kuo HC; Chen CM; Lee-Chen GJ; Hu FJ; Chu CC; Liou CW; Huang CC
J Neurol Sci; 2009 Mar; 278(1-2):21-4. PubMed ID: 19101703
[TBL] [Abstract][Full Text] [Related]
14. Oculopharyngeal muscular dystrophy (OPMD) due to a small duplication in the PABPN1 gene.
van der Sluijs BM; van Engelen BG; Hoefsloot LH
Hum Mutat; 2003 May; 21(5):553. PubMed ID: 12673802
[TBL] [Abstract][Full Text] [Related]
15. Ectopic expression of a polyalanine expansion mutant of poly(A)-binding protein N1 in muscle cells in culture inhibits myogenesis.
Wang Q; Bag J
Biochem Biophys Res Commun; 2006 Feb; 340(3):815-22. PubMed ID: 16378590
[TBL] [Abstract][Full Text] [Related]
16. The dynamism of PABPN1 nuclear inclusions during the cell cycle.
Marie-Josée Sasseville A; Caron AW; Bourget L; Klein AF; Dicaire MJ; Rouleau GA; Massie B; Langelier Y; Brais B
Neurobiol Dis; 2006 Sep; 23(3):621-9. PubMed ID: 16860991
[TBL] [Abstract][Full Text] [Related]
17. Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear polyA-binding protein with a single-domain intracellular antibody.
Verheesen P; de Kluijver A; van Koningsbruggen S; de Brij M; de Haard HJ; van Ommen GJ; van der Maarel SM; Verrips CT
Hum Mol Genet; 2006 Jan; 15(1):105-11. PubMed ID: 16319127
[TBL] [Abstract][Full Text] [Related]
18. Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus.
Berciano MT; Villagra NT; Ojeda JL; Navascues J; Gomes A; Lafarga M; Carmo-Fonseca M
Hum Mol Genet; 2004 Apr; 13(8):829-38. PubMed ID: 14976164
[TBL] [Abstract][Full Text] [Related]
19. Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice.
Davies JE; Wang L; Garcia-Oroz L; Cook LJ; Vacher C; O'Donovan DG; Rubinsztein DC
Nat Med; 2005 Jun; 11(6):672-7. PubMed ID: 15864313
[TBL] [Abstract][Full Text] [Related]
20. Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation.
Davies JE; Sarkar S; Rubinsztein DC
Hum Mol Genet; 2008 Apr; 17(8):1097-108. PubMed ID: 18178579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
